Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
Posted on: Monday, 17 September 2007, 09:00 CDT
RESTON, Va., Sept. 17 /PRNewswire/ -- Mirixa Corporation, a leading developer of innovative clinical solutions that facilitate pharmacist-based patient care services, today announced the immediate availability of version 2.2 of the MirixaPro(TM) product suite (MirixaPro 2.2). With this latest release of MirixaPro, pharmacies nationwide have fingertip access to an enhanced array of clinical care management tools that streamline pharmacy-based delivery of targeted patient care services including medication therapy management (MTM), medication adherence and disease management.
Leveraging Mirixa's technology, pharmacists have delivered tens of thousands of targeted MTM patient interventions, resolved thousands of alerts indicating potential safety issues and worked actively with patients and physicians to improve medication-related care. Qualifying patient cases are delivered directly and securely to the pharmacist, along with the patient's medication history. MirixaPro's workflow system supports delivery of multiple interventions through a single Web-based interface.
"Medication non-adherence and inadequate medication management is nothing short of a national epidemic," says Eric Zimmerman, Chief Innovation Officer and General Manager of Mirixa Clinical. "About 50% of patients with chronic conditions do not take their medications correctly -- we can and must do far better. At Mirixa, we're convinced the solution starts by levering the 'triangle of trust' between patients, physicians and pharmacists.
"MirixaPro makes collaboration easier by using data to pinpoint care improvement opportunities, monitor progress, and speed the flow of information across a secure network of care. The results so far are encouraging -- every day we hear from pharmacists using our technologies to collaborate with physicians to close gaps in care, resolve safety risks, and help consumers become confident and successful in managing their health," added Zimmerman.
MirixaPro 2.2 will be previewed by industry leaders at the Health 2.0 Conference on September 20 in San Francisco, CA as well as at the NACDS Medication Therapy Management Services in Community Pharmacy Conference September 19-20 in Philadelphia, PA.
About Mirixa
Mirixa Corporation is a leading developer of innovative clinical solutions that facilitate pharmacist-based patient care services and a leader in Medication Therapy Management (MTM) technology solutions. Founded by the National Community Pharmacists Association (NCPA), Mirixa has assembled the largest pharmacy services network of its kind with over 40,000 contracted community pharmacies -- including both independents and chains. Mirixa's technology portfolio empowers the delivery of highly targeted medication management programs, patient education, recruitment campaigns and patient medication records. The company's leadership team shares a vision and passion for improving patient care, reducing overall health costs, and expanding consumer access to accurate medication information. Mirixa is headquartered in the heart of the Dulles Technology Corridor in Reston, VA; with offices in California, Texas and New Jersey. For more information visit http://www.mirixa.com/.
Contact: Liz Deakin Mirixa Corporation Phone: 703-600-1226 E-mail: ldeakin@mirixa.com
Mirixa Corporation
CONTACT: Liz Deakin of Mirixa Corporation, +1-703-600-1226,ldeakin@mirixa.com
Web site: http://www.mirixa.com/
Source: PRNewswire
Related Articles
- Medical Care Corporation Enables Early Detection of Memory Loss Due to Alzheimer's Disease
- Boston Scientific Releases Remote Monitoring Data From Its Wireless LATITUDE(R) Patient Management System
- Fresenius Medical Care Announces 2007 Disaster Preparedness Plan to Ensure Vital Dialysis Care During Hurricanes
- Clinical Pharmacists Can Positively Contribute to Clinical Outcomes for HIV-Infected Patients
- Fresenius Medical Care Announces 2006 Disaster Preparedness Plan to Ensure Vital Dialysis Care for Patients During Hurricanes
- Healthcare Compliance Services Company Reaches Agreement With ALR Technologies to Provide the ALRT500 Disease Management Compliance Reminder and Monitoring System to Selected Chronic Care Patient Population
- Renal Care Group Signs Agreement to Sell Required Facilities in Connection With Fresenius Medical Care Transaction
- Medical Care Corporation Leads Effort to Provide Early Detection of Alzheimer's Disease
- Fresenius Medical Care Announces Changes of Corporate Credit Rating
- Orphan Medical Announces Patient Enrollment is Complete in Clinical Trial Assessing Xyrem for the Treatment of Fibromyalgia Syndrome
 |
 |
User Comments (0)
RSS Feeds